P05.93 Adult medulloblastoma: analysis of use of chemotherapy in clinical practice

BACKGROUND: Adult medulloblastoma (MB) is rare, accounting for 150–300 new cases in the US annually. Given the low incidence, prospective studies are challenging, and the role of adjuvant chemotherapy in standard risk patients has been controversial. Currently, the best evidence available (Level V)...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Mastall, M, Majd, N, Fuller, G, Gule-Monroe, M, Huse, J, Khatua, S, Rao, G, Sandberg, D, Wefel, J, Yeboa, D, Zaky, W, Mahajan, A, Puduvalli, V, Suki, D, Alfaro, K, Weathers, S, Harrison, R, de Groot, J, Penas-Prado, M
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2018
Matèries:
Poster Presentations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6144716/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy139.419
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars